These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26861549)

  • 1. Overexpressed transcription factor FOXM1 contributes to the progression of colorectal cancer.
    Zhang H; Zhong H; Li L; Ji W; Zhang X
    Mol Med Rep; 2016 Mar; 13(3):2696-700. PubMed ID: 26861549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer.
    Zhang HG; Xu XW; Shi XP; Han BW; Li ZH; Ren WH; Chen PJ; Lou YF; Li B; Luo XY
    Clin Transl Oncol; 2016 May; 18(5):527-32. PubMed ID: 26370421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
    Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
    J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
    Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
    Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
    Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
    Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
    Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
    Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of miR-6868-5p/FOXM1 circuit contributes to colorectal cancer angiogenesis.
    Wang Y; Wu M; Lei Z; Huang M; Li Z; Wang L; Cao Q; Han D; Chang Y; Chen Y; Liu X; Xue L; Mao X; Geng J; Chen Y; Dai T; Ren L; Wang Q; Yu H; Chen C; Chu X
    J Exp Clin Cancer Res; 2018 Nov; 37(1):292. PubMed ID: 30486864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of forkhead box M1 (FoxM1) expression and antitumour effect of FoxM1 inhibition in melanoma.
    Ito T; Kohashi K; Yamada Y; Maekawa A; Kuda M; Furue M; Oda Y
    Histopathology; 2016 Jul; 69(1):63-71. PubMed ID: 26619071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interaction of GLUT1 and FOXM1 Leads to a Poor Prognosis in Colorectal Cancer.
    Kuai XY; Lei ZY; Liu XS; Shao XY
    Anticancer Agents Med Chem; 2020; 20(8):941-950. PubMed ID: 32188390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer.
    Yang Y; Jiang H; Li W; Chen L; Zhu W; Xian Y; Han Z; Yin L; Liu Y; Wang Y; Pan K; Zhang K
    Aging (Albany NY); 2020 Dec; 12(23):24424-24440. PubMed ID: 33291076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy.
    Uddin S; Ahmed M; Hussain A; Abubaker J; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Jehan Z; Bavi P; Siraj AK; Al-Kuraya KS
    Am J Pathol; 2011 Feb; 178(2):537-47. PubMed ID: 21281787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paeoniflorin inhibits cell growth and induces cell cycle arrest through inhibition of FoxM1 in colorectal cancer cells.
    Yue M; Li S; Yan G; Li C; Kang Z
    Cell Cycle; 2018; 17(2):240-249. PubMed ID: 29301438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Forkhead BOX M1 (FOXM1) gene expression in colorectal cancer.
    Rather TB; Parveiz I; Bhat GA; Rashid G; Wani RA; Khan IY; Mudassar S
    Clin Exp Med; 2023 Oct; 23(6):2385-2405. PubMed ID: 36318377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXM1 promotes invasion and migration of colorectal cancer cells partially dependent on HSPA5 transactivation.
    Luo X; Yao J; Nie P; Yang Z; Feng H; Chen P; Shi X; Zou Z
    Oncotarget; 2016 May; 7(18):26480-95. PubMed ID: 27034162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.
    Yoshida Y; Wang IC; Yoder HM; Davidson NO; Costa RH
    Gastroenterology; 2007 Apr; 132(4):1420-31. PubMed ID: 17408638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonic Hedgehog-dependent proliferation in a series of patients with colorectal cancer.
    Douard R; Moutereau S; Pernet P; Chimingqi M; Allory Y; Manivet P; Conti M; Vaubourdolle M; Cugnenc PH; Loric S
    Surgery; 2006 May; 139(5):665-70. PubMed ID: 16701100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXM1 and FOXQ1 Are Promising Prognostic Biomarkers and Novel Targets of Tumor-Suppressive miR-342 in Human Colorectal Cancer.
    Weng W; Okugawa Y; Toden S; Toiyama Y; Kusunoki M; Goel A
    Clin Cancer Res; 2016 Oct; 22(19):4947-4957. PubMed ID: 27162244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1.
    Zheng S; Zhou C; Wang Y; Li H; Sun Y; Shen Z
    J Exp Clin Cancer Res; 2020 Jan; 39(1):23. PubMed ID: 31992359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer.
    Xu M; Shao X; Li H; Zhang Z; Zhou C; Cheng Z
    Sci Rep; 2020 Nov; 10(1):20160. PubMed ID: 33214609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.